The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((1-(4-bromobenzyl)-4-(phenylamino)piperidin-4-yl)methyl)-2-guanidinoacetamide ID: ALA3361431
Chembl Id: CHEMBL3361431
PubChem CID: 118724991
Max Phase: Preclinical
Molecular Formula: C22H29BrN6O
Molecular Weight: 473.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)NCC(=O)NCC1(Nc2ccccc2)CCN(Cc2ccc(Br)cc2)CC1
Standard InChI: InChI=1S/C22H29BrN6O/c23-18-8-6-17(7-9-18)15-29-12-10-22(11-13-29,28-19-4-2-1-3-5-19)16-27-20(30)14-26-21(24)25/h1-9,28H,10-16H2,(H,27,30)(H4,24,25,26)
Standard InChI Key: QYTUZIWLELWSHU-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 473.42Molecular Weight (Monoisotopic): 472.1586AlogP: 2.50#Rotatable Bonds: 8Polar Surface Area: 106.27Molecular Species: BASEHBA: 4HBD: 5#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 11.10CX LogP: 1.65CX LogD: -0.97Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.30Np Likeness Score: -0.90
References 1. Journigan VB, Mésangeau C, Vyas N, Eans SO, Cutler SJ, McLaughlin JP, Mollereau C, McCurdy CR.. (2014) Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptors., 57 (21): [PMID:25268943 ] [10.1021/jm500989n ]